Publicação

Deciphering the mechanisms underlying bovine milk lactoferrin anticancer activity using yeast and cancer cell lines as complementary models

Ver documento

Detalhes bibliográficos
Resumo:Lactoferrin (Lf) is a milk derived iron-binding protein that exhibits a broad range of interesting biological activities, from which its anticancer and antifungal activities stand out. Our group has been elucidating the mechanisms and identifying the molecular targets underlying Lf anticancer/antifungal activities in order to improve its therapeutic efficacy and rational application. Indeed, we previously demonstrated that Lf triggers a mitochondrial and caspase-dependent regulated cell death in Saccharomyces cerevisiae (1). Moreover, we found that Lf selectively induces apoptosis in highly metastatic cell lines displaying the proton pump V-ATPase at the plasma membrane (2). However, much work is needed to further characterize Lf mechanisms of action. In the present work, we show how functional genomic approaches using yeast deletion mutants provided new insights on the activity of Lf against yeast that were then validated in human cancer cell lines. Results will be discussed in an integrated manner regarding their contribution towards understanding the molecular basis of Lf anticancer activity. In addition, this study highlights the great potential of yeast as a model to uncover mechanisms of action occurring in the more complex human cells. References (1) Acosta-Zaldívar M, Andrés MT, Rego A, Pereira CS, Fierro JF, Côrte-Real M. (2016) Human lactoferrin triggers a mitochondrial- and caspase-dependent regulated cell death in Saccharomyces cerevisiae. Apoptosis. 21(2):163-73. doi: 10.1007/s10495-015-1199-9. (2) Pereira CS, Guedes JP, Gonçalves M, Loureiro L, Castro L, Gerós H, Rodrigues LR, Côrte-Real M. (2016) Lactoferrin selectively triggers apoptosis in highly metastatic breast cancer cells through inhibition of plasmalemmal V-H+-ATPase. Oncotarget. 7(38):62144-62158. doi: 10.18632/oncotarget.11394.
Autores principais:Pereira, Cátia Sofia Santos
Outros Autores:Guedes, Joana P.; Chaves, Susana Alexandra Rodrigues; Andrés, María T.; Fierro, José F.; Gerós, H.; Rodrigues, L. R.; Côrte-Real, Manuela
Ano:2018
País:Portugal
Tipo de documento:outro
Tipo de acesso:acesso aberto
Instituição associada:Universidade do Minho
Idioma:inglês
Origem:RepositóriUM - Universidade do Minho
Descrição
Resumo:Lactoferrin (Lf) is a milk derived iron-binding protein that exhibits a broad range of interesting biological activities, from which its anticancer and antifungal activities stand out. Our group has been elucidating the mechanisms and identifying the molecular targets underlying Lf anticancer/antifungal activities in order to improve its therapeutic efficacy and rational application. Indeed, we previously demonstrated that Lf triggers a mitochondrial and caspase-dependent regulated cell death in Saccharomyces cerevisiae (1). Moreover, we found that Lf selectively induces apoptosis in highly metastatic cell lines displaying the proton pump V-ATPase at the plasma membrane (2). However, much work is needed to further characterize Lf mechanisms of action. In the present work, we show how functional genomic approaches using yeast deletion mutants provided new insights on the activity of Lf against yeast that were then validated in human cancer cell lines. Results will be discussed in an integrated manner regarding their contribution towards understanding the molecular basis of Lf anticancer activity. In addition, this study highlights the great potential of yeast as a model to uncover mechanisms of action occurring in the more complex human cells. References (1) Acosta-Zaldívar M, Andrés MT, Rego A, Pereira CS, Fierro JF, Côrte-Real M. (2016) Human lactoferrin triggers a mitochondrial- and caspase-dependent regulated cell death in Saccharomyces cerevisiae. Apoptosis. 21(2):163-73. doi: 10.1007/s10495-015-1199-9. (2) Pereira CS, Guedes JP, Gonçalves M, Loureiro L, Castro L, Gerós H, Rodrigues LR, Côrte-Real M. (2016) Lactoferrin selectively triggers apoptosis in highly metastatic breast cancer cells through inhibition of plasmalemmal V-H+-ATPase. Oncotarget. 7(38):62144-62158. doi: 10.18632/oncotarget.11394.